MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221

Untitled work

(2008) · doi:10.1038/nrg2290 · Cited by 5,199

Classification of primary progressive aphasia and its variants

Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141

The Western Diet Regulates Hippocampal Microvascular Gene Expression: An Integrated Genomic Analyses in Female Mice

Nuthikattu, S., Milenković, D., Rutledge, J. C., & Villablanca, A. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-55533-9 · Cited by 27

Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

Furr, J. W., Morales‐Scheihing, D., Manwani, B., Lee, J., & McCullough, L. D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08568-0 · Cited by 29

Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery

Yoon, H., Belmonte, K. C., Kasten, T., Bateman, R., & Kim, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13031-w · Cited by 26

A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice

Prieto-Fernández, E., Aransay, A. M., Royo, F., González, E., Lozano, J. J., Santos-Zorrozua, B., Macias-Camara, N., González, M., Garay, R. P., Benito, J., et al. (2019) · Theranostics · doi:10.7150/thno.31502 · Cited by 28

Study on the mechanism of curcumin to reduce the inflammatory response of temporal lobe in Alzheimer's disease by regulating miR-146a

Jingfeng, G. O. N. G., & Derong, S. U. N. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.06463-0 · Cited by 30

MicroRNA Alterations in Induced Pluripotent Stem Cell-Derived Neurons from Bipolar Disorder Patients: Pathways Involved in Neuronal Differentiation, Axon Guidance, and Plasticity

Bame, M., McInnis, M. G., & O’Shea, K. S. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0046 · Cited by 25

Identification of Peripheral Blood miRNA Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy

Jin, M., Zhu, X., Sun, Y., Li, Z., Li, X., Ai, L., He, Y., Liu, Y., Jia, N., Hu, G., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02878-4 · Cited by 27

Neuroepigenetics and Alzheimer’s Disease: An Update

Zusso, M., Barbierato, M., Facci, L., Skaper, S. D., & Giusti, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180259 · Cited by 28

High-Throughput Platforms in Real-Time PCR and Applications

Lamas, A., Franco, C. M., Regal, P., Miranda, J. M., Vázquez, B. I., & Cepeda, A. (2016) · InTech eBooks · doi:10.5772/65760 · Cited by 25

Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration

MARATOVICH, B. A., Al-Yozbaki, M., George, A., Niyazova, R. Y., Sharipov, K. O., Byrne, L. J., & Wilson, C. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210817150141 · Cited by 27

Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression

Wortelboer, K., Bakker, G. J., Winkelmeijer, M., van Riel, N. A. W., Levin, E., Nieuwdorp, M., Herrema, H., & Davids, M. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.126972 · Cited by 25

Recent advances in molecular biomarkers for diabetes mellitus: a systematic review

Lees, T., Nassif, N. T., Simpson, A. M., Shad-Kaneez, F., Martiniello‐Wilks, R., Lin, Y., Jones, A. S., Qu, X., & Lal, S. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1279216 · Cited by 25

MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study

Kopková, A., Šáňa, J., Fadrus, P., Macháčková, T., Večeřa, M., Vybíhal, V., Juráček, J., Vychytilova‐Faltejskova, P., Smrčka, M., & Slabý, O. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208580 · Cited by 25

MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice

Jiang, Y., Zhang, Y., & Su, L. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00217-w · Cited by 24

Exosomes as Possible Spread Factor and Potential Biomarkers in Alzheimer'S Disease: Current Concepts

Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0034 · Cited by 25

Molecular Regulation of Cellular Senescence by MicroRNAs: Implications in Cancer and Age-Related Diseases

Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23

Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer’s Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes

Kim, S. H., Choi, K. Y., Park, Y., McLean, C., Park, J., Lee, J. H., Lee, K., Kim, B. C., Huh, Y. H., Lee, K. H., et al. (2021) · Cells · doi:10.3390/cells10102697 · Cited by 23

Vincamine alleviates amyloid-β 25-35 peptides-induced cytotoxicity in PC12 cells

Han, J., Qu, Q., Qiao, J., & Zhang, J. (2016) · Pharmacognosy Magazine · doi:10.4103/0973-1296.196309 · Cited by 22

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease

Eddin, A. N., Hamsho, K., Adi, G., Al-Rimawi, M., Alfuwais, M., Rab, S. A., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1210191 · Cited by 26

Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases

Choi, J., Kim, S., Kwak, H., Park, D., Park, J., Ryu, J., Park, C., & Kang, J. (2017) · International Neurourology Journal · doi:10.5213/inj.1734961.458 · Cited by 22

Circulating MicroRNAs from Serum Exosomes May Serve as a Putative Biomarker in the Diagnosis and Treatment of Patients with Focal Cortical Dysplasia

Chen, S., Pan, H.-Y., Huang, J.-B., Liu, X.-P., Li, J.-H., Ho, C.-J., Tsai, M., Yang, J., Chen, S., Chen, N.-C., et al. (2020) · Cells · doi:10.3390/cells9081867 · Cited by 21

MicroRNA exocytosis by large dense-core vesicle fusion

Gümürdü, A., Yildiz, R., Eren, E., Karakülah, G., Ünver, T., Genç, Ş., & Park, Y. (2017) · Scientific Reports · doi:10.1038/srep45661 · Cited by 21

Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

Sousa, R. A. L. D., & Caria, A. C. I. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00903-y · Cited by 19

A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression

Wang, W., Fardo, D. W., Jicha, G. A., & Nelson, P. T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0316-2 · Cited by 20

MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain

Gugliandolo, A., Chiricosta, L., Boccardi, V., Mecocci, P., Bramanti, P., & Mazzon, E. (2020) · Genes · doi:10.3390/genes11090983 · Cited by 20

Osteoblast-Derived Lipocalin-2 Regulated by miRNA-96-5p/Foxo1 Advances the Progression of Alzheimer’s Disease

Wu, B.-W., Guo, J.-D., Wu, M.-S., Liu, Y., Lu, M., Zhou, Y.-H., & Han, H.-W. (2020) · Epigenomics · doi:10.2217/epi-2019-0215 · Cited by 20

MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease

Wijesinghe, P., Xi, J., Cui, J. Z., Campbell, M., Pham, W. N., & Matsubara, J. A. (2023) · Life Science Alliance · doi:10.26508/lsa.202201757 · Cited by 20

Recent Developments in Circulating Biomarkers in Parkinson’s Disease: The Potential Use of Mirnas in A Clinical Setting

dos Santos, M. C. T., Bell, R., & da Costa, A. N. (2016) · Bioanalysis · doi:10.4155/bio-2016-0166 · Cited by 19

The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions

Baichurina, I., Владимирович, В. В., James, V. H., Rizvanov, A. A., & Mukhamedshina, Y. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010114 · Cited by 18

A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy

Nonaka, W., Takata, T., Iwama, H., Komatsubara, S., Kobara, H., Kamada, M., Deguchi, K., Touge, T., Miyamoto, O., Nakamura, T., et al. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12604 · Cited by 18

MicroRNAs mediate the anti-tumor and protective effects of ginsenosides

Ashrafizadeh, M., Ahmadi, Z., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1675722 · Cited by 18

Extracellular microRNAs as messengers in the central and peripheral nervous system

Scott, H. (2017) · Neuronal Signaling · doi:10.1042/ns20170112 · Cited by 19

MicroRNAs As Novel Biomarkers and Potential Therapeutic Options for Inflammatory Cardiomyopathy

Aleshcheva, G., Baumeier, C., Harms, D., Bock, C.-T., Escher, F., & Schultheiss, H.-P. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14523 · Cited by 17

Epigenetics in Alzheimer’s Disease: A Critical Overview

Villa, C., & Combi, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115970 · Cited by 18

Circulating microRNAs disclose biology of normal cognitive function in healthy elderly people – a discovery twin study

Mengel‐From, J., Feddersen, S., Halekoh, U., Heegaard, N. H. H., McGue, M. K., Christensen, K., Tan, Q., & Christiansen, L. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0157-8 · Cited by 17

Network Profiling of Brain-Expressed X-Chromosomal MicroRNA Genes Implicates Shared Key MicroRNAs in Intellectual Disability

Gonçalves, T. F., Piergiorge, R. M., dos Santos, J. M., Gusmão, J., Pimentel, M. M. G., & Santos-Rebouças, C. B. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1235-7 · Cited by 16

Performance of Validated MicroRNA Biomarkers for Alzheimer’s Disease in Mild Cognitive Impairment

Sandau, U. S., Wiedrick, J. T., Smith, S. J., McFarland, T. J., Lusardi, T. A., Lind, B., Harrington, C. A., Lapidus, J., Galasko, D. R., Quinn, J. F., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200396 · Cited by 16

Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective

Bandakinda, M., & Mishra, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126561 · Cited by 16

The Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease

Bufill, E., Nogué, R. R., & Blesa, R. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch9 · Cited by 15

Identification of miRNA and Their Regulatory Effects Induced by Total Flavonoids From Dracocephalum moldavica in the Treatment of Vascular Dementia

Liu, M., Shan, G., Jiang, H., Zeng, L., Zhao, K., Li, Y., Ashraf, G. M., Li, Z., & Liu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.796628 · Cited by 15

Circ_0002945 functions as a competing endogenous RNA to promote Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SK-N-SH cells and human primary neurons

Li, G., Liang, R., Lian, Y., & Zhou, Y. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147878 · Cited by 15

miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease

Delay, C., Grenier‐Boley, B., Amouyel, P., Dumont, J., & Lambert, J. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0186-x · Cited by 15

MicroRNA-219 alleviates glutamate-induced neurotoxicity in cultured hippocampal neurons by targeting calmodulin-dependent protein kinase II gamma

Xu, F., Wang, T., Cai, Q., Yang, W., Fan, H.-H., & Yi, J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235059 · Cited by 15

NeurimmiRs and Postoperative Delirium in Elderly Patients Undergoing Total Hip/Knee Replacement: A Pilot Study

Dong, R., Sun, L., Lu, Y., Yang, X., Peng, M., & Zhang, Z. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00200 · Cited by 14

MiR-375 Has Contrasting Effects on Newcastle Disease Virus Growth Depending on the Target Gene

Wang, X., Jia, Y., Wang, C., Wang, C., Lv, C., Li, X., Chu, Z., Zhang, S., Xiao, S., Zhang, S., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25106 · Cited by 14

Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease

Slota, J. A., Medina, S. J., Klassen, M., Gorski, D., Mesa, C., Robertson, C., Mitchell, G. B., Coulthart, M. B., Pritzkow, S., Soto, C. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56249-6 · Cited by 14

Circulating microRNAs as novel diagnostic biomarkers and prognostic predictors for septic patients

Yao, J., Lui, K. Y., Hu, X., Liu, E., Zhang, T., Li, T., Xu, J., Fa, H., Zhu, Y., Lu, M.-Q., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105082 · Cited by 13

MicroRNA Exocytosis by Vesicle Fusion in Neuroendocrine Cells

Park, Y. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00355 · Cited by 260

miR-146a Regulates Neuroinflammation and Immune Cell Function in Neurodegenerative Diseases

Xiong, J.-R., Yan, Z.-Y., Shi, M., Zhou, G., Zhang, J.-H., Xu, J., Liao, Y., & Tang, H. (2025) · Current Medical Science · doi:10.1007/s11596-025-00080-w · Cited by 15

Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy

Pavelka, L., Rauschenberger, A., Hemedan, A. A., Ostaszewski, M., Glaab, E., Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae187 · Cited by 11

The Underexploited Role of Non-Coding RNAs in Lysosomal Storage Diseases

de Queiroz, M. T., Pereira, V. G., do Nascimento, C. C., & D’Almeida, V. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00133 · Cited by 12

Transcriptome sequencing reveals aerobic exercise training-associated lncRNAs for improving Parkinson’s disease

Zhang, X., Wang, Y., Zhao, Z., Chen, X., Li, W., & Li, X. (2020) · 3 Biotech · doi:10.1007/s13205-020-02483-z · Cited by 12

Next-generation biosensor technologies for Alzheimer’s disease: Innovations in diagnosis, monitoring, and treatment

Yin, C., Tang, X., Zeng, J., Wang, Z., Mi, J., Liang, Y. J., Qin, D., Feng, Q., & Wu, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102954 · Cited by 13

Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches

Vogrinc, D., Goričar, K., Kunej, T., & Dolžan, V. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100946 · Cited by 11

CDC42 expression is altered by dioxin exposure and mediated by multilevel regulations via AhR in human neuroblastoma cells

Xu, T., Xie, H. Q., Li, Y., Xia, Y., Chen, Y., Xu, S. L., Wang, L., & Zhao, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-10311-3 · Cited by 11

Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington’s Disease Model

Zsindely, N., Nagy, G., Siági, F., Farkas, A., & Bodai, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511942 · Cited by 11

MiRNA a new insight in metabolic and human diseases: A review

Jafri, I. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.8.16 · Cited by 10

JAMIR-eQTL: Japanese genome-wide identification of microRNA expression quantitative trait loci across dementia types

Akiyama, S., Higaki, S., Ochiya, T., Ozaki, K., Niida, S., & Shigemizu, D. (2021) · Database · doi:10.1093/database/baab072 · Cited by 10

A preliminary model of football-related neural stress that integrates metabolomics with transcriptomics and virtual reality

Vike, N. L., Bari, S., Stetsiv, K., Walter, A. E., Newman, S. D., Kawata, K., Bazarian, J. J., Martinovich, Z., Nauman, E. A., Talavage, T. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103483 · Cited by 10

Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury

Cente, M., Matyasova, K., Csicsatkova, N., Tomikova, A., Porubska, S., Niu, Y., Majdan, M., Filipcik, P., & Jurisica, I. (2022) · Cellular and molecular neurobiology · doi:10.1007/s10571-022-01254-z · Cited by 9

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

Toivonen, J. M., Sánz-Rubio, D., López-Pérez, Ó., Marín‐Moreno, A., Bolea, R., Osta, R., Badiola, J. J., Zaragoza, P., Espinosa, J. C., Torres, J. M., et al. (2020) · Biomolecules · doi:10.3390/biom10060908 · Cited by 9

CD38 and MGluR1 as possible signaling molecules involved in epileptogenesis: A potential role for NAD+ homeostasis

Khodaverdian, S., Dashtban-Moghadam, E., Dabirmanesh, B., Mirnajafi‐Zadeh, J., Taleb, M., Khajeh, K., & Fathollahi, Y. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147509 · Cited by 9

Non-coding RNA biomarkers in Alzheimer’s disease

Mohammadpour, M., Saeidi, K., Ferdosi, F., Khanifar, H., Dadgostar, E., Zakizadeh, F., Abdolghaderi, S., & Khatami, S. H. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120427 · Cited by 8

Diagnostic and prognostic value of microRNAs for Alzheimer’s disease: a comprehensive meta-analysis

Cătană, C.-S., Crișan, C., Opre, D., & Berindan‐Neagoe, I. (2020) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1393 · Cited by 8

Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategies

Sharma, D., Srivastava, S., & Babu, M. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10639-4 · Cited by 8

Can Astrocytes Be a Target for Precision Medicine?

Allen, C. F., Shaw, P. J., & Ferraiuolo, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_7 · Cited by 7

Integrating multi-omics with neuroimaging and behavior: A preliminary model of dysfunction in football athletes

Bari, S., Vike, N. L., Stetsiv, K., Walter, A. E., Newman, S. D., Kawata, K., Bazarian, J. J., Papa, L., Nauman, E. A., Talavage, T. M., et al. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2021.100032 · Cited by 7

Profiling Secreted miRNA Biomarkers of Chemical-Induced Neurodegeneration in Human iPSC-Derived Neurons

You, D., Cohen, J. D., Pustovalova, O., Lewis, L., & Shen, L. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac011 · Cited by 8

miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach

Pereira, J. D., Teixeira, L. C. R., Mamede, I., Alves, M. T., Caramelli, P., Luizon, M. R., Veloso, A., & Gomes, K. B. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16060 · Cited by 6

Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy

Siegismund, C. S., Rohde, M., Kühl, U., Escher, F., Schultheiß, H., & Laßner, D. (2016) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.04.005 · Cited by 6

Differential expression of microRNA in serum fractions and association of Argonaute 1 microRNAs with heart failure

Meiri, E., Volinsky, N., Dromi, N., Kredo‐Russo, S., Benjamin, H., Tabak, S., Marmor, H., Motin, M., Lebanony, D., Lithwick‐Yanai, G., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15306 · Cited by 6

Association between different dimensions of childhood traumatization and plasma micro-RNA levels in a clinical psychiatric sample

der Auwera, S. V., Ameling, S., Nauck, M. A., Völzke, H., Völker, U., & Grabe, H. J. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.023 · Cited by 6

miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease

Elzayat, E. M., Shahien, S. A., El-Sherif, A. A., & Hosney, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221298 · Cited by 7

Circulating miR-505-5p as a Diagnostic Marker for Acute Cerebral Infarction and Its Predictive Value for Clinical Outcomes After Endovascular Mechanical Thrombectomy

Ruan, J., Zhou, J., Li, G., Peng, T., Zhang, J., & Wei, B. (2024) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2024.j085 · Cited by 5

Oral Delivery of miR-320-3p with Lipidic Aminoglycoside Derivatives at Mid-Lactation Alters miR-320-3p Endogenous Levels in the Gut and Brain of Adult Rats According to Early or Regular Weaning

Tavares, G. A., Torres, A., Dréan, G. L., Queignec, M., Castellano, B., Tesson, L., Remy, S., Anegón, I., de Souza, S. L., Pitard, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010191 · Cited by 8

Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease

Chauhan, S., Behl, T., Sehgal, A., Singh, S., Sharma, N., Gupta, S., Albratty, M., Najmi, A., Meraya, A. M., & Alhazmi, H. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00621-4 · Cited by 6

An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer’s Disease

Gordon, M. L., Christen, E., Keehlisen, L., Gong, M. N., Lam, F., Giliberto, L., Gomar, J. J., & Koppel, J. L. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240089 · Cited by 7

miRNA375-3p/rapamycin mediates the mTOR pathway by decreasing PS1, enhances microglial cell activity to regulate autophagy in Alzheimer's disease

Wang, Y., Xiao, Z., Yin, H., Ren, Z., Ma, X., Wang, Y., Zhang, Y., Fu, X., Zhang, F., & Zeng, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37589 · Cited by 5

Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer’s Disease

Ryan, M., Tan, V. T. Y., Thompson, N., Guévremont, D., Mockett, B. G., Tate, W. P., Abraham, W. C., Hughes, S. M., & Williams, J. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200757 · Cited by 6

Amyloid-β-Induced Neurotoxicity Modulates miR-98 and miR-200 Expression in SH-SY5Y Cells: A Step Toward Alzheimer’s Biomarker Discovery

Keske, E., Ebrahımı, A., & Sağlam-Uçar, Ö. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04895-5 · Cited by 6

Transcriptome profiling of cerebrospinal fluid in Alzheimer's disease reveals molecular dysregulations associated with disease

Sota, R. E. D., Berghuis, B. A., Khoury, S., Zhuang, J., Rissman, R. A., Brewer, J. B., Quake, S. R., Sninsky, J. J., & Toden, S. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70152 · Cited by 4

POCT devices for neurodegenerative disorders: from lab to clinics

Parihar, A., Choudhary, N. K., & Khan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00015-6 · Cited by 5

Mesenchymal Stem Cells from Familial Alzheimer’s Patients Express MicroRNA Differently

Rochín-Hernández, L. J., Rochín‐Hernández, L. S., Padilla-Cristerna, M. L., Duarte-García, A., Jiménez-Acosta, M. A., Figueroa‐Corona, M. D. P., & Meraz‐Ríos, M. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031580 · Cited by 4

Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance

Adiga, D., Eswaran, S., Sriharikrishnaa, S., Khan, N. G., Kumar, D., & Kabekkodu, S. P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266293212240405042540 · Cited by 4

Novel miRNA biomarkers for genotoxicity screening in mouse

Oka, H., Masuno, K., Uehara, T., Okamoto, T., Matsuura, Y., Nakano, T., & Yamaguchi, S. (2018) · Toxicology · doi:10.1016/j.tox.2018.05.009 · Cited by 4

Potential of sperm small non-coding RNAs as biomarkers of testicular toxicity in a doxorubicin-induced mouse model

Sakai, K., Hiradate, Y., Hara, K., & Tanemura, K. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101160 · Cited by 4

Plasma MicroRNAs Are Altered Early and Consistently in a Mouse Model of Tauopathy.

Ryan, B., Williams, J. M., & Curtis, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.036 · Cited by 5

Pin1 Regulatory miRNAs as Novel Candidates for Alzheimer’s Disease TreatmentPreprint

Heidari, E., Siavashani, E. S., Rasooli, M., Amiri, Z., Sharifi‐Zarchi, A., & Shahpasand, K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/472985 · Cited by 4

Discovery of miRNAs Unique to Actively Transcribed Erythroparvovirus Infection in Heart Failure Patients

Aleshcheva, G., Salih, S., Baumeier, C., Escher, F., Bock, C. –., & Schultheiß, H. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15194 · Cited by 3

Analytics of Cerebrospinal Fluid MicroRNA Quantitative PCR Studies

Lusardi, T. A., Wiedrick, J. T., Malone, M., Phillips, J. I., Sandau, U. S., Lind, B., Quinn, J. F., Lapidus, J., & Saugstad, J. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1422-0 · Cited by 3

Can Genetic Markers Predict the Sporadic Form of Alzheimer’s Disease? An Updated Review on Genetic Peripheral Markers

Theron, D., Hopkins, L. N., Sutherland, H. G. E., Griffiths, L. R., & Fernandez, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713480 · Cited by 4

Small Non-Coding RNAs

Rederstorff, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2547-6 · Cited by 3

miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives

Kosikova, N., Cente, M., Cigánková, V., Koson, P., & Filipčík, P. (2018) · General Physiology and Biophysics · doi:10.4149/gpb_2018019 · Cited by 3

EXPRESSION OF SELECTED miRNAs IN CIRCULATING BLOOD OF EARLY AND LATE-ONSET ALZHEIMER DISEASE PATIENTS

Güven, G., Lohmann, E., Güleç, Ç., Bılgıç, B., Özer, E., Hanağası, H. A., Gurvit, H. I., & Erginel‐Ünaltuna, N. (2021) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.2020.0061 · Cited by 4

miR-449a mediated repression of the cell cycle machinery prevents neuronal apoptosis

Chauhan, M., Singh, K., Chongtham, C., Aneeshkumar, A. G., & Sharma, P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107698 · Cited by 3

Current and Developing Methods for Diagnosing Alzheimer's Disease

Fuller, S. J., Carrigan, N., Sohrabi, H. R., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch3 · Cited by 2

Alterations in the Expression Levels of miR-9-5p and miR-4467 in Peripheral Blood of Patients with First-Episode SchizophreniaPreprint

Jin, M., Zhu, X., Sun, Y., Li, Z., Li, X., He, Y., Liu, Y., Jia, N., Hu, G., Cui, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-731032/v1 · Cited by 2

Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke

Eyileten, C., Wicik, Z., Gąsecka, A., Ahmadova, S., Martino, M. T. D., Mucha, J., Mirowska-Guzel, D. M., Rosa, S. D., Kurkowska-Jastrzębska, I., Członkowska, A., et al. (2026) · BMC Medical Genomics · doi:10.1186/s12920-025-02302-5 · Cited by 1

Clinical applications of microRNAs

Thillaiyampalam, G., & Cristino, A. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00013-3 · Cited by 1

Some News on Old Concepts and the Epigenetics of Alzheimer’s Disease

Cacabelos, R. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100079 · Cited by 1

MicroRNA profiling of CSF in Alzheimerʼs disease

Jahn, H., & Denk, J. (2015) · Pharmacopsychiatry · doi:10.1055/s-0035-1557962

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease

Lusardi, T. A., Phillips, J. I., Wiedrick, J. T., Harrington, C. A., Lind, B., Lapidus, J., Quinn, J. F., & Saugstad, J. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160835 · Cited by 135

CSF microRNA Profiling in Alzheimer’s Disease: a Screening and Validation Study

Dangla-Valls, A., Molinuevo, J. L., Altirriba, J., Sánchez‐Valle, R., Alcolea, D. A., Fortea, J., Rami, L., Balasa, M., Muñoz-García, C., Ezquerra, M., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0106-x · Cited by 53

Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid

Wiedrick, J. T., Phillips, J. I., Lusardi, T. A., McFarland, T. J., Lind, B., Sandau, U. S., Harrington, C. A., Lapidus, J., Galasko, D. R., Quinn, J. F., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180539 · Cited by 81

O3‐02–07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

Richardson, J. C., Cogswell, J. P., Ward, J. M., Taylor, I. A., Waters, M., Shi, Y., Cannon, B. D., Kelnar, K., Kemppainen, J., Brown, D., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.420 · Cited by 18